Nabeela Nathoo, MD, PhD, FRCPC (@neuronathoo) profile picture

MS/Neuroimmunology Neurologist & Assistant Professor @UAlberta_FoMD | Alum: @MayoClinicNeuro, @UAlberta_FoMD, @UCalgaryMed, @HotchkissBrain | Views=my own

Edmonton, Alberta
Joined December 2010
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Can you help us reach 150 responses? 130 people with MS have completed our 5 min anonymous survey on MS & Abuse - 20 to go! Whether or not you've experienced abuse, ur voice matters. Help us understand the scale of domestic abuse in the MS community Link: lnkd.in/g5PN_yZV
6
13
1
18
860
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Neurology Podcast: Drs. Stacey Clardy and Justin Abbatemarco discuss why #infection can be overlooked in people on anti-CD20 therapy and practical ways clinicians can improve testing, prevention, vaccination, and collaboration. Listen now: hubs.la/Q04DVsZM0 @StaceyLClardy
2
3
1
4
2,005
Nabeela Nathoo, MD, PhD, FRCPC retweeted
A great joy of a PD is watching former residents thrive! Wonderful to see this article highlighting clinical accomplishments of Dr. @SamanthaBanksMD, a former chief. A testament to her dedication to patient care, clinical excellence, and leadership. -A Proud PD @mayoneurores
1
5
21
791
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Spinal cord involvement in histiocytic neoplasms is underrecognized, and it's often how the disease first shows up. With effective MAPK-targeted therapies (BRAF/MEK) available, early diagnosis matters. In @GreenJournal, we studied 415 patients with ECD, LCH and RDD from the @MayoClinic cohort: 🔹 10% had spinal cord or nerve root involvement
🔹 In 1 of every 2 symptomatic patients, it was the FIRST sign of the disease
🔹 ECD → mainly cord infiltration; RDD → mainly nerve roots or extrinsic compression
🔹 Improvement after treatment: RDD 91%, LCH 67%, ECD only 46% 👉 Think spinal MRI early in patients with neurologic symptoms or high-risk features. 🔗 neurology.org/doi/10.1212/WN…
#NeuroTwitter @Histiocytosis @HistiocyteSoc
2
12
36
2,516
Thrilled to share our review on safety of complement inhibitors (eculizumab, ravulizumab) during pregnancy in NMOSD & MG-->early case data + larger PNH/aHUS cohorts show no consistent harm signal, but more studies specifically in NMOSD and MG are needed rdcu.be/3JLEUmTqXXta
1
7
19
679
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Delighted to share our international review on MRI Characteristics of #MOGAD! ➡️ Key imaging features are highlighted across the brain, optic nerves & spinal cord including lesion dynamics ➡️ Illustrative figures help show its full imaging spectrum👇 jamanetwork.com/journals/jam…
9
84
2
238
21,394
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Ethnicity does not strongly correlate with multiple sclerosis severity. Senior author @drruthdobson onlinelibrary.wiley.com/doi/…
1
8
27
2,063
Nabeela Nathoo, MD, PhD, FRCPC retweeted
3.1 million people are now living with MS worldwide. Published today, this new estimate draws on data from 133 countries, representing 93% of the world's population. It provides the most comprehensive picture of global MS prevalence and incidence to date. msintfederation.org/4cMl0FV
3
6
303
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Enterovirus infection in B-cell depleted patients may cause severe central nervous system involvement, and early IVIg and investigational antivirals may be considered. Narrative review with two illustrative cases from @AKunchok @ClevelandClinic ▶️ journals.sagepub.com/doi/10.…
2
6
18
1,032
Nabeela Nathoo, MD, PhD, FRCPC retweeted
We're proud to introduce the inaugural Michelle Ploughman Award, as part of this year's Annual Research Competition, recognizing and supporting the next generation of #MS rehabilitation researchers. Apply for an endMS Personnel Award. Learn more: bit.ly/4qmenzC
2
4
380
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Thank you, @GreenJournal, for inviting me to discuss our paper! As a bonus, we also talked about how to diagnose amyloid neuropathy. This is one of my favorite neuropathy topics, so I spoke a lot. 😅 I hope you will enjoy it! open.spotify.com/episode/6oI…
11
1
36
4,328
Nabeela Nathoo, MD, PhD, FRCPC retweeted
Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis: hubs.la/Q04kbZpG0
1
30
1
84
4,985
Nabeela Nathoo, MD, PhD, FRCPC retweeted
A 37-year-old woman with #MultipleSclerosis treated with ofatumumab developed enteroviral encephalitis (with fever, confusion, seizures, altered consciousness, and residual neuropsychiatric symptoms). Case report from @UofT @StMichaelsFdn ▶️ journals.sagepub.com/doi/ful… 1/🧵
2
2
12
641
An honour to get to be part of such a momentous occasion, at the first African MS conference (@Africtrims) in Ghana, though sadly virtually for me!
Replying to @neuronathoo
@neuronathoo describing Multiple Sclerosis epidemiology in Africa!
7
258
An excellent episode reframing how we view and approach palliative care in #multiplesclerosis by 2 powerhouse neurologists out of @UAlberta_DoM
Listen to Drs. Penelope Smyth and Janis M. Miyasaki discuss their article on “Palliative Care in Multiple Sclerosis" in the April #MultipleSclerosis and Related Disorders issue. Episode out on all podcast platforms or at hubs.la/Q04hb8H10
1
6
312
Nabeela Nathoo, MD, PhD, FRCPC retweeted
A case report of Enteroviral encephalitis in a 37 year old woman taking kesimpta for multiple sclerosis. IgG was normal and IgM was low. MRI brain (image) shows symmetrical lesions in the thalamus. She improved but with ongoing neuropsychiatric symptoms journals.sagepub.com/doi/10.…
2
14
47
3,365
Nabeela Nathoo, MD, PhD, FRCPC retweeted
7 Tesla MRI of the spinal cord in multiple sclerosis reveals lesions which were invisible on 3 Tesla MRI. pubmed.ncbi.nlm.nih.gov/4203…
6
13
2
66
3,680